Previous 10 | Next 10 |
2023-08-16 16:34:05 ET More on Vivos Therapeutics Vivos Therapeutics, Inc. ( VVOS ) Q1 2023 Earnings Call Transcript Vivos stock surges ~30% on acquiring dental product rights from Advanced Facialdontics Vivos Therapeutics shares slide premarket on pricing $8M pr...
Operating Expenses Decreased 31% Quarter Over Quarter and 25% Year to Date, Reflecting Cost Cutting Initiatives Management to Host Conference Call Today at 6:00 pm ET LITTLETON, Colo., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the...
Vivos Therapeutics (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from a variety of health conditions, many of which are associated with breathing related sleep conditions arising from cert...
LITTLETON, Colo., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from a variet...
Vivos Therapeutics (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from a variety of health conditions, many of which are associated with breathing related sleep conditions arising from cert...
LITTLETON, Colo., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from a ...
Vivos Therapeutics (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from a variety of health conditions, many of which are associated with breathing-related sleep issues arising from certain ...
LITTLETON, Colo., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from a variet...
2023-08-08 07:19:43 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re starting off the day with a look at all of the biggest pre-market stock movers worth keeping an eye on for Tuesday! Moving stocks this morning are earnings reports, a bankruptc...
--News Direct-- Vivos Therapeutics chairman and CEO Kirk Huntsman joins Natalie Stoberman from the Proactive studios to discuss the company's first-quarter financial and operational highlights. Huntsman says the main highlight of comes from acquisition of certain US and international ...
News, Short Squeeze, Breakout and More Instantly...
Vivos Therapeutics Inc. Company Name:
VVOS Stock Symbol:
NASDAQ Market:
Vivos Therapeutics Inc. Website:
LITTLETON, Colo., June 27, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company” (NASDAQ:VVOS) , a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments f...
Vivos Therapeutics (NASDAQ: VVOS) is a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders (including all severities of obstructive sleep apnea (“OSA”) i...
Alliance with Sleep Treatment Provider in Colorado Marks Critical Pivot in Vivos’ Marketing and Distribution Model Aimed at Enhancing Revenue Streams and Potential Profit Private Placement Investment Sponsored by Seneca Partners, Who Will Also Provide General Management Advisory ...